Amgen Announces Top-Line Results of Phase 3 Head and Neck Cancer Trial

August 11th, 2010 | Health News Category : Health Issues,Pharma

Amgen (Nasdaq: AMGN) today announced top-line results from a randomized Phase 3 trial evaluating Vectibix(R) (panitumumab) as a first-line treatment in patients with recurrent and/or metastatic squamous cell head and neck cancer.

Original Source of Amgen Announces Top-Line Results of Phase 3 Head and Neck Cancer Trial

Related tweets from Twitter:

mariaconzemius : Can someone explain to me how birth control pills can be considered basic health care? It doesn't make sense to me.
2012-02-12T23:24:08Z - Reply - View Tweet
WayneTCortez : Zac Efron: 'Thousands of Calories' for 'The Lucky One' http://t.co/2TTNi5Mz #dieting #health
2012-02-12T23:24:07Z - Reply - View Tweet
breizh2008 : Preventive Medicine Can Save Your Life http://t.co/ZvFV2WOP
2012-02-12T23:24:06Z - Reply - View Tweet
HealthCareShake : #HealthCareShake Republicans sign on to legal brief in challenge to Obama's federal health care ... http://t.co/97MLx4rr
2012-02-12T23:24:05Z - Reply - View Tweet
katloveslovato : RT @LovaticEpicness: Lol you guys need to realize that without Demi's health there is no Demi music. SO CHILL OUT.
2012-02-12T23:24:05Z - Reply - View Tweet